Literature DB >> 18393050

Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants.

James J Mahoney1, Ari D Kalechstein, Richard De La Garza, Thomas F Newton.   

Abstract

The primary objective of this study was to compare and contrast psychotic symptoms reported by cocaine- and methamphetamine-dependent individuals. Participants included 27 cocaine-dependent and 25 methamphetamine-dependent males, as well as 15 cocaine-dependent and 18 methamphetamine-dependent females. After screening, participants were excluded if they met criteria for any Axis I diagnosis other than nicotine dependence, or methamphetamine or cocaine dependence (ie, participants had to use either methamphetamine or cocaine but were excluded if they met dependence criteria for both). The participants were administered the newly developed Psychotic Symptom Assessment Scale (PSAS), which assesses psychotic symptoms. A high proportion of both cocaine- and methamphetamine-dependent men and women reported delusions of paranoia and auditory hallucinations. However, during the abstinent and intoxicated conditions, methamphetamine-dependent men and women were more likely than cocaine-dependent men and women to report psychotic symptoms. Future studies will compare psychotic symptoms reported by non-dependent recreational stimulant users to stimulant-dependent individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393050      PMCID: PMC4119877          DOI: 10.1080/10550490701861201

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  19 in total

1.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

Authors:  R L Spitzer; J B Williams; M Gibbon; M B First
Journal:  Arch Gen Psychiatry       Date:  1992-08

Review 2.  Pyrolytic characteristics, pharmacokinetics, and bioavailability of smoked heroin, cocaine, phencyclidine, and methamphetamine.

Authors:  C E Cook
Journal:  NIDA Res Monogr       Date:  1991

3.  Fundamental mechanisms underlying altered behavior following chronic administration of psychomotor stimulants.

Authors:  E H Ellinwood; M M Kilbey
Journal:  Biol Psychiatry       Date:  1980-10       Impact factor: 13.382

4.  The prevalence of psychotic symptoms among methamphetamine users.

Authors:  Rebecca McKetin; Jennifer McLaren; Dan I Lubman; Leanne Hides
Journal:  Addiction       Date:  2006-10       Impact factor: 6.526

5.  Clinical features of cocaine-induced paranoia.

Authors:  S L Satel; S M Southwick; F H Gawin
Journal:  Am J Psychiatry       Date:  1991-04       Impact factor: 18.112

Review 6.  Stimulant psychosis: systematic review.

Authors:  Catherine Curran; Neetha Byrappa; Andrew McBride
Journal:  Br J Psychiatry       Date:  2004-09       Impact factor: 9.319

7.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

8.  Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report.

Authors:  A Iwanami; A Sugiyama; N Kuroki; S Toda; N Kato; Y Nakatani; N Horita; T Kaneko
Journal:  Acta Psychiatr Scand       Date:  1994-06       Impact factor: 6.392

9.  Cocaine-induced psychosis.

Authors:  K T Brady; R B Lydiard; R Malcolm; J C Ballenger
Journal:  J Clin Psychiatry       Date:  1991-12       Impact factor: 4.384

10.  Kinetics of cocaine in humans after intravenous and intranasal administration.

Authors:  J I Javaid; M N Musa; M Fischman; C R Schuster; J M Davis
Journal:  Biopharm Drug Dispos       Date:  1983 Jan-Mar       Impact factor: 1.627

View more
  33 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

Review 2.  Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Authors:  Tong H Lee; Steven T Szabo; J Corey Fowler; Paolo Mannelli; O Barry Mangum; Wayne F Beyer; Ashwin Patkar; William C Wetsel
Journal:  Drug Alcohol Depend       Date:  2012-02-21       Impact factor: 4.492

3.  A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.

Authors:  Peter D Alexander; Kristina M Gicas; Taylor S Willi; Clara N Kim; Veronika Boyeva; Ric M Procyshyn; Geoff N Smith; Allen E Thornton; William J Panenka; Andrea A Jones; Fidel Vila-Rodriguez; Donna J Lang; G William MacEwan; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2017-02-11       Impact factor: 4.530

Review 4.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

5.  Psychiatric comorbidity in methamphetamine dependence.

Authors:  Ruth Salo; Keith Flower; Anousheh Kielstein; Martin H Leamon; Thomas E Nordahl; Gantt P Galloway
Journal:  Psychiatry Res       Date:  2010-11-04       Impact factor: 3.222

6.  Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.

Authors:  James J Mahoney; Rollin Y Hawkins; Richard De La Garza; Ari D Kalechstein; Thomas F Newton
Journal:  Gend Med       Date:  2010-10

7.  Methamphetamine-Induced Cognitive Deficits and Psychiatric Symptoms Are Associated with Serum Markers of Liver Damage.

Authors:  Tingting Zhao; Changping Zhai; Hongmei Song; Yanhai Wu; Chuanhui Ge; Yonglin Zhang; Hongxia Xu; Zhengsuo Chi; Hui Chu; Wei Shi; Xiaodong Cheng; Xin Li; Mengdi Ma; Mengyuan Xu; Jiaqi Hu; Ya Xie; Yanan Lin; Hongxu Chen; Yiting Li; Dongliang Jiao
Journal:  Neurotox Res       Date:  2019-11-05       Impact factor: 3.911

8.  Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.

Authors:  Rasmon Kalayasiri; Viroj Verachai; Joel Gelernter; Apiwat Mutirangura; Robert T Malison
Journal:  Addiction       Date:  2014-03-17       Impact factor: 6.526

9.  Aripiprazole and Risperidone for Treatment of Methamphetamine-Associated Psychosis in Chinese Patients.

Authors:  Gang Wang; Yao Zhang; Sheng Zhang; Huijing Chen; Zaifeng Xu; Richard S Schottenfeld; Wei Hao; Marek Cezary Chawarski
Journal:  J Subst Abuse Treat       Date:  2015-11-26

Review 10.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Psychiatr Clin North Am       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.